Updated Jul 16, 2026
Piacquad David has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Piacquad David is referenced in SEC filings related to Neumora Therapeutics, Inc. as of May 29, 2026, indicating an insider role with the company. Publicly available information on this exact spelling of the name is limited, and the specific title or duties are not disclosed in the provided data. Based on the SEC context, the individual appears to be involved in governance or management at Neumora Therapeutics, but further confirmation from company disclosures would be needed for a precise role.
| Role | Insider |
|---|---|
| Notability | 60/100 |
Piacquad David is referenced in SEC filings related to Neumora Therapeutics, Inc. as of May 29, 2026, indicating an insider role with the company. Publicly available information on this exact spelling of the name is limited, and the specific title or duties are not disclosed in the provided data. Based on the SEC context, the individual appears to be involved in governance or m…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Piacquad David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.